Comparison of the Surgical Facemask With the Double-trunk Mask on Oxygenation in COVID-19

The Effects of Two Systems Above Low-flow Nasal Cannula on Arterial Oxygen Tension in Patients With COVID-19 : Surgical Face Mask Versus Double-trunk Mask

This study will compare the impact of two systems above low-flow nasal cannula on the arterial oxygen tension in patients with COVID-19. The two systems are the Surgical Mask (SM) and the Double-Trunk Mask (DTM).

Study Overview

Detailed Description

Hospitalized patients with COVID-19 typically present with hypoxemia. In some patients, hypoxemia can be corrected with low flow nasal cannula. When placed above nasal cannula, some systems have demonstrated their interest in improving the performance of patient's oxygen delivery. For example, two recent studies have shown that adding a Double-Trunk Mask (DTM) or Surgical Mask (SM) above nasal cannula has the potential to improve the PaO2 despite no change in oxygen output (Duprez et al., J Clin Monit Comput 2020; Montiel et al., Ann Intensive Care 2020). However, there is no study comparing the relative effectiveness of these 2 systems.

Study Type

Interventional

Enrollment (Actual)

27

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Brussels, Belgium, 1200
        • Cliniques Universitaires Saint-luc

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years and older (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • COVID-19 positive
  • SpO2 between 92 and 96% with low-flow oxygen therapy
  • Oxygen output at baseline between 3 and 7 L/min.

Exclusion Criteria:

  • Pulmonary disease with hypercapnia
  • Confusion
  • Contra-indications to arterial blood gas sampling (peripheral arteriopathy, bleeding disorder)

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Supportive Care
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Single

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Low-flow nasal cannula
The standard oxygen delivery system (low-flow nasal cannula) is worn by the patient, without the DTM or the SM
The standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.
Experimental: Double-Trunk Mask
The Double-Trunk Mask is placed above the standard oxygen delivery system (low-flow nasal cannula).
The Double-Trunk Mask above the standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.
Experimental: Surgical Mask
The Surgical Mask is placed above the standard oxygen delivery system (low-flow nasal cannula).
The Surgical Mask above the standard oxygen delivery system (low-flow nasal cannula or oxygen mask) is worn by the patient for 1 hour.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Changes in PaO2
Time Frame: At baseline and 30 minutes after wearing the randomized oxygen delivery system
Oxygen tension (PaO2) in mmHg will be analyzed from a sample taken from the arterial system
At baseline and 30 minutes after wearing the randomized oxygen delivery system

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in PaCO2
Time Frame: At baseline and 30 minutes after wearing the randomized oxygen delivery system
Carbon dioxide tension (PaCO2) in mmHg will be analyzed from a sample taken from the arterial system.
At baseline and 30 minutes after wearing the randomized oxygen delivery system
Change in pH
Time Frame: At baseline and 30 minutes after wearing the randomized oxygen delivery system
Potential of Hydrogen (pH) will be analyzed from a sample taken from the arterial system.
At baseline and 30 minutes after wearing the randomized oxygen delivery system
Change in respiratory rate
Time Frame: At baseline, 30 minutes and 60 minutes after wearing the randomized oxygen delivery system
Respiratory rate is measured during one minute by visual inspection.
At baseline, 30 minutes and 60 minutes after wearing the randomized oxygen delivery system
Change in dyspnea
Time Frame: At baseline and 60 minutes after wearing the randomized oxygen delivery system
Dyspnea is rated with a visual analogic scale (0 to 100mm).
At baseline and 60 minutes after wearing the randomized oxygen delivery system
Change in O2 output
Time Frame: At 30 minutes and 60 minutes after wearing the randomized oxygen delivery system
The O2 output will be adjusted to recover the baseline SpO2 reading. The O2 output will be read from the position of the ball inside the flowmeter.
At 30 minutes and 60 minutes after wearing the randomized oxygen delivery system

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

November 13, 2020

Primary Completion (Actual)

March 5, 2021

Study Completion (Actual)

March 5, 2021

Study Registration Dates

First Submitted

November 13, 2020

First Submitted That Met QC Criteria

November 13, 2020

First Posted (Actual)

November 16, 2020

Study Record Updates

Last Update Posted (Actual)

March 9, 2021

Last Update Submitted That Met QC Criteria

March 8, 2021

Last Verified

March 1, 2021

More Information

Terms related to this study

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Covid19

Clinical Trials on Standard Oxygen Delivery System

Subscribe